Asset Details
Do you wish to reserve the book?
Molecular diagnosis of viral hepatitis in the WHO African region: progress toward 2030 elimination goals
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Molecular diagnosis of viral hepatitis in the WHO African region: progress toward 2030 elimination goals
Do you wish to request the book?
Molecular diagnosis of viral hepatitis in the WHO African region: progress toward 2030 elimination goals
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Molecular diagnosis of viral hepatitis in the WHO African region: progress toward 2030 elimination goals
2025
Overview
The WHO African Region bears a disproportionately high burden of hepatitis B and C virus infections, yet molecular diagnostic capacity remains limited, impeding accurate detection, treatment monitoring, and surveillance. This Letter highlights the critical role of molecular diagnostics, including nucleic acid amplification tests, viral load quantification, and genotypic characterization, in achieving the United Nations’ 2030 viral hepatitis elimination targets. I have discussed the infrastructural, financial, and logistical challenges constraining molecular testing in the region, and underscore emerging innovations such as point-of-care viral load assays and portable sequencing technologies. Prioritizing accessible molecular diagnostics and genomic surveillance within national hepatitis control programs is essential to bridge existing gaps and advance toward global elimination goals.
Publisher
BioMed Central,BioMed Central Ltd,BMC
Subject
/ Biomedical and Life Sciences
/ Comment
/ Control
/ Genotype
/ Hepacivirus - isolation & purification
/ Hepatitis B - prevention & control
/ Hepatitis C - prevention & control
/ Hepatitis, Viral, Human - diagnosis
/ Hepatitis, Viral, Human - epidemiology
/ Hepatitis, Viral, Human - prevention & control
/ Hepatitis, Viral, Human - virology
/ Humans
/ Molecular Diagnostic Techniques - methods
/ Nucleic Acid Amplification Techniques
/ Virology
We currently cannot retrieve any items related to this title. Kindly check back at a later time.